S 2036 New Jersey Senate · 2026-2027 Regular Session

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

This bill adds xylazine to New Jersey's Schedule III controlled substances list, meaning it is now classified as a controlled drug with specific legal restrictions. The exception explicitly allows veterinarians to prescribe, administer, or dispense xylazine for animal care without violating the law. Illegally possessing, distributing, or using xylazine would become a third-degree crime, punishable by up to five years in prison and fines up to $35,000. This change directly affects people who misuse xylazine outside of veterinary contexts, while leaving veterinary practice unaffected.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026 Last action Jan 13, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 1 co-sponsor

Sponsors